Autoimmune lymphoproliferative syndrome type 2 is an autosomal dominant disorder caused by mutations of the CASP10 gene, associated with increased risk of Hodgkin and non-Hodgkin lymphomas.
Lymphoproliferative syndrome | ||||
Autoimmune lymphoproliferative syndrome type 2 | ||||
CASP10 | ||||
Lymphoproliferative syndrome 1 | ||||
X-linked lymphoproliferative syndrome 1 | ||||
X-linked lymphoproliferative syndrome 2 | ||||
1. |
Wang J et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. |
2. |
Zhu S et al. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. |
3. |
Sneller MC et al. (1997) Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. |